Felipe Batalini, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Astrazeneca
    Topic:
    PARPi
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Merck
    Topic:
    PARPi
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Daiichi-Sankyo
    Topic:
    Antibody-drug conjugates
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Novartis
    Topic:
    CDK4/6i
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Illumina/Grail
    Topic:
    DNA sequencing
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    CARIS
    Topic:
    DNA sequencing
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Foundation Medicine
    Topic:
    DNA sequencing
    Date added:
    11/11/2023
    Date updated:
    11/11/2023
Return to BTF Best of ASH & SABCS 2024, Phoenix